Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000019636 | SCV004293831 | pathogenic | Hereditary antithrombin deficiency | 2023-03-23 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SERPINC1 protein function. ClinVar contains an entry for this variant (Variation ID: 18020). This variant is also known as Ala382>Thr. This missense change has been observed in individual(s) with antithrombin III deficiency (PMID: 2615648, 3179438, 24684277, 25466846, 28300866). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 414 of the SERPINC1 protein (p.Ala414Thr). |
Mayo Clinic Laboratories, |
RCV004791231 | SCV005413972 | pathogenic | not provided | 2024-08-27 | criteria provided, single submitter | clinical testing | PP1, PP3, PM1, PM2_moderate, PS4 |
OMIM | RCV000019636 | SCV000039934 | pathogenic | Hereditary antithrombin deficiency | 1996-01-01 | no assertion criteria provided | literature only |